论文信息 - TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma - 字舞流文

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma

J. Zedenius | Johan O Paulsson | C. Juhlin | F. Haglund | Anton Olander

[1] C. Larsson,et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. , 2018, Endocrine-related cancer.

[2] A. Farooqi,et al. MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets , 2018, International journal of molecular sciences.

[3] Chang-sheng Chen,et al. Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma , 2017, Oncotarget.

[4] M. Simoni,et al. Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization , 2015, Molecular and Cellular Endocrinology.

[5] B. Schäfer,et al. Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression , 2000, British Journal of Cancer.